MEG, Wada & Functional Mapping

Magnetoencephalography (MEG), the Wada test, and functional MRI complement standard clinical neurophysiology by providing spatial functional mapping of cortical regions. MEG records magnetic fields generated by neural activity with millisecond temporal resolution and 1–2 cm spatial accuracy; the Wada test uses transient hemispheric anesthesia to lateralize language and memory; functional MRI maps task-related cortical activation with high spatial resolution. Together they support diagnostic and surgical planning in epilepsy, brain tumors, and complex neurosurgical procedures. This page covers each technique, its clinical applications, and the integration into multimodal evaluation.

Magnetoencephalography (MEG)

Principles

• Records magnetic fields generated by neuronal activity.
• Magnetic fields don’t suffer the spatial smoothing of electric fields by skull and scalp.
• SQUIDs (superconducting quantum interference devices) detect tiny magnetic fluctuations.
• Requires magnetically shielded room.
• Source localization more accurate than scalp EEG (1–2 cm vs 6+ cm for routine EEG).

Recording

• Patient lies still with head positioned in helmet-shaped SQUID array.
• Typical systems have 200+ channels.
• Simultaneous EEG often recorded for cross-validation.
• Subject performs task or rests.

Clinical Applications

Epilepsy Surgical Planning

• Source localization of interictal spikes.
• Helps identify epileptogenic focus when scalp EEG is unclear.
• Particularly useful for non-lesional cases.
• Sensitivity for IED detection: similar to scalp EEG with better localization.
• Complements MRI and scalp EEG in pre-surgical evaluation.

Functional Mapping

• Maps eloquent cortex (motor, somatosensory, language).
• Less invasive than direct cortical mapping.
• Particularly useful for pre-operative tumor planning.

Neurodegenerative Disease

• Research applications in AD, frontotemporal dementia, parkinsonism.
• Some emerging clinical uses for biomarkers.

MS

• Detects functional abnormalities in normal-appearing white matter.
• Research applications.

Advantages of MEG

• Better spatial accuracy than scalp EEG.
• Excellent temporal resolution.
• Non-invasive.
• Can be combined with simultaneous EEG.

Limitations

• Very expensive equipment and shielded room.
• Limited availability (few centers).
• Patient must remain still.
• Some sources (radially oriented dipoles) are difficult to detect.
• Insensitive to fields generated by tangentially oriented sources at depth.

Wada Test (Intracarotid Amobarbital Procedure)

Principle

• Amobarbital injected into one carotid artery via catheter.
• Temporarily anesthetizes the hemisphere supplied by that artery.
• Allows testing of language and memory function in each hemisphere separately.

Procedure

• Catheter advanced via femoral artery to internal carotid.
• Test injection: small dose to verify hemisphere coverage.
• Therapeutic injection: full dose temporarily anesthetizes hemisphere.
• While that hemisphere is anesthetized:
  • Language: patient asked to name, repeat, comprehend (in non-anesthetized hemisphere).
  • Memory: items presented for later recall.
• Other side tested days later if needed.

Interpretation

• Language: deficit during one side’s anesthesia indicates language localizes to that side.
• Memory: deficit on subsequent testing of items presented during anesthesia indicates memory adequacy of the non-anesthetized hemisphere.

Clinical Use

• Pre-temporal lobectomy: assesses risk of post-op memory loss.
• Determines if non-operated hemisphere can support memory after resection.
• Lateralizes language.

Risks

• Procedural risks of catheter angiography: ~1–2%.
• Stroke (rare but reported).
• Vasospasm.
• Contrast reaction.

Modern Status

• Largely replaced by fMRI for language lateralization (less invasive).
• Still used at some centers for memory assessment when fMRI insufficient.
• Modern Wada protocols emphasize selective injection (PCA, MCA branches).

Functional MRI (fMRI)

Principles

• Measures blood oxygen level-dependent (BOLD) signal.
• Active brain regions have increased blood flow → increased oxyhemoglobin.
• Indirect measure of neural activity.
• Spatial resolution: 1–3 mm.
• Temporal resolution: seconds.

Task-Based fMRI

• Patient performs specific task during scan.
• Active regions identified by BOLD signal change.
• Tasks: language (naming, comprehension), motor (finger tapping), sensory (touching), memory.

Resting-State fMRI

• No task required.
• Identifies intrinsic connectivity networks.
• Useful for patients unable to cooperate with tasks.
• Emerging clinical applications.

Clinical Applications

Pre-Surgical Mapping

• Maps language, motor, sensory cortex relative to tumor or lesion.
• Largely replaced Wada for language lateralization.
• Non-invasive.
• Limitations: signal artifact near brain lesions, requires patient cooperation.

Epilepsy

• Localizes language and motor cortex for surgical planning.
• Some applications in localizing seizure onset (less reliable).

Memory Assessment

• More challenging than language fMRI.
• Some centers use fMRI activation in mesial temporal regions for memory lateralization.
• Wada still preferred at some centers.

Aphasia/Stroke Recovery

• Tracks reorganization during recovery.
• Research applications.

Multimodal Integration

Modern pre-surgical workup often combines:

• Scalp EEG.
• Video EEG monitoring.
• MRI (structural).
• fMRI (functional mapping).
• MEG (source localization).
• PET (interictal metabolism).
• SPECT (ictal perfusion).
• Neuropsychological testing.
• Wada test (memory, sometimes language).
• Intracranial EEG (if Phase I non-localizing).

Each modality contributes complementary information.

Comparing the Techniques

Future Directions

Combined Modalities

• Simultaneous EEG-fMRI for source localization with high spatial-temporal resolution.
• EEG-fMRI guides interpretation of each.
• Research and emerging clinical applications.

Multimodal Imaging

• PET-MRI for combined metabolism and structure.
• SPECT-MRI for ictal perfusion + anatomy.
• Improving epilepsy surgical decision-making.

Machine Learning

• Automated detection of epileptic activity.
• Improved source localization.
• Prediction of surgical outcomes.
• Pattern recognition in EEG and MEG data.

Wearable Technologies

• Dry-electrode EEG for ambulatory monitoring.
• OPM-MEG (optically pumped magnetometers) — emerging technology that may make MEG more accessible.

🔍 Did You Know?

The integration of multimodal pre-surgical evaluation for epilepsy — combining scalp EEG, MRI, MEG, PET, SPECT, fMRI, neuropsychological testing, and sometimes intracranial monitoring — has substantially improved surgical outcomes over the past two decades. Modern epilepsy centers approach the patient with refractory epilepsy through a structured workflow: scalp EEG (semiology, lateralization), MRI (structural), MEG (functional), PET/SPECT (metabolic/perfusional), neuropsychological testing (lateralization), and Wada (memory adequacy). Each technique answers a different question: “where do seizures start?” “what’s the underlying lesion?” “is the eloquent cortex at risk?” “will memory be preserved?” Combining these answers — typically in a multi-disciplinary pre-surgical conference — produces surgical plans that account for all relevant factors and minimize the risk of post-operative deficits. The result: seizure freedom rates of 70%+ in lesional cases with concordant findings, and 50%+ in non-lesional cases requiring intracranial monitoring. The clinical implication is that complex epilepsy benefits from comprehensive multimodal evaluation at specialized centers, not just routine workup at general neurology practices. For practicing neurologists, the take-home is to refer drug-resistant epilepsy patients to specialized centers early — within 2 years of refractory status, not after a decade of failed medications. The same multimodal evaluation principle applies to other complex neurologic conditions: brain tumors near eloquent cortex, complex movement disorders requiring DBS, and multiple sclerosis with atypical presentation — all benefit from integrated assessment combining functional, structural, electrophysiologic, and behavioral data. Modern neurology is increasingly multimodal, and the skilled clinician integrates findings from each modality to produce coherent diagnoses and management plans.

Pitfalls and Pearls

• MEG: magnetic field detection; better spatial accuracy than scalp EEG (1–2 cm vs 6+ cm).
• MEG: epilepsy source localization, functional mapping; requires shielded room.
• Wada test: hemispheric anesthesia; tests language and memory lateralization.
• Wada now largely replaced by fMRI for language; sometimes used for memory.
• Wada risks: catheter angiography risks (~1–2% stroke risk).
• fMRI: BOLD signal; high spatial resolution; slow temporal.
• Task-based fMRI: standard for pre-surgical mapping.
• Resting-state fMRI: connectivity networks; for non-cooperative patients.
• fMRI for language lateralization: replaces Wada at most centers.
• fMRI for memory: more challenging; Wada still useful sometimes.
• Multimodal integration: scalp EEG + MRI + MEG + PET + SPECT + fMRI + neuropsych + Wada + intracranial.
• Each modality answers different questions: where, what, who’s at risk, prognosis.
• Modern epilepsy surgery: 70%+ seizure freedom with comprehensive evaluation.
• Refer drug-resistant epilepsy early: within 2 years, not after decades.
• Future: simultaneous EEG-fMRI, multimodal imaging, machine learning, OPM-MEG.
• Modern neurology is multimodal: integrated diagnostic approach.

References

1. Stufflebeam SM, Tanaka N, Ahlfors SP. Clinical applications of magnetoencephalography. Hum Brain Mapp. 2009;30(6):1813-1823.
2. Knowlton RC. The role of FDG-PET, ictal SPECT, and MEG in the epilepsy surgery evaluation. Epilepsy Behav. 2006;8(1):91-101.
3. Loring DW, Meador KJ. Wada testing in epilepsy surgery. Curr Opin Neurol. 2018;31(2):164-167.
4. Janecek JK, Swanson SJ, Sabsevitz DS, et al. Language lateralization by fMRI and Wada testing in 229 patients with epilepsy: rates and predictors of discordance. Epilepsia. 2013;54(2):314-322.
5. Lee A, Tan EK. Function imaging in epilepsy. Neurology. 2009;72(20 Suppl 5):S5-S11.
6. Engel J Jr. The current place of epilepsy surgery. Curr Opin Neurol. 2018;31(2):192-197.